Natixis Investment Managers International’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,709
Closed -$25K 233
2022
Q3
$25K Sell
3,709
-63,931
-95% -$1.06M ﹤0.01% 228
2022
Q2
$1.32M Sell
67,640
-14,877
-18% -$312K 0.03% 181
2022
Q1
$1.79M Buy
82,517
+4,846
+6% +$103K 0.03% 142
2021
Q4
$1.83M Buy
77,671
+6,058
+8% +$145K 0.1% 57
2021
Q3
$1.87M Buy
71,613
+3,770
+6% +$91.2K 0.11% 54
2021
Q2
$1.64M Buy
67,843
+59,203
+685% +$1.46M 0.1% 59
2021
Q1
$215K Buy
8,640
+1,855
+27% +$49.1K 0.01% 161
2020
Q4
$186K Buy
+6,785
New +$182K 0.01% 187

Other funds holding SHC

Natixis Investment Managers International's SHC Position: Q4 2022 in Review

Natixis Investment Managers International sold out of Sotera Health (SHC) in Q4 2022, closing a stake of 3,709 shares — an estimated $25K sold.

Natixis Investment Managers International first reported a position in SHC in Q4 2020 and held it in 8 quarters. The position peaked at $1.87M in Q3 2021. 172 funds tracked by Wall St. Rank hold SHC as of Q4 2022.

  • Natixis Investment Managers International reported no remaining Sotera Health position as of Q4 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 3,709 Sotera Health shares in Q4 2022, an estimated $25K.
  • Natixis Investment Managers International first reported a position in Sotera Health in Q4 2020 and held it in 8 quarters.
  • Natixis Investment Managers International's Sotera Health position peaked at $1.87M in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Sotera Health as of Q4 2022.

Based on Natixis Investment Managers International's 13F filing for Q4 2022, filed 13 Feb 2023.